3 must-see videos for diabetes care

Photo: matucha12/Adobe Stock

Christopher Pachel, DVM, DACVB, CABC; Karen Roach, RVT, VTS (ECC); and Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ, offer unique perspectives about caring for patients with diabetes in a series of interviews with dvmn360. Each of these experts recently delivered continuing education sessions at Fetch dvm360 conferences, sharing their knowledge with attendees in Kansas City, Missouri, and Atlantic City, New Jersey. The 3 videos that follow further convey their informative insights:

The impact of medical conditions on feline behavior

Christopher Pachel, DVM, DACVB, CABC, discussed various medical conditions in felines—including arthritis and osteoarthritis, and endocrine disorders like hyperthyroidism and diabetes—that can show up as behavioral changes, in an interview with dvm360. He also discussed changes in eating habits, irritability and stress thresholds, and what these changes could mean.

An education in emergency and critical care: DKA

Karen Roach, RVT, VTS (ECC), a training mentor at Mount Laurel Animal Hospital in New Jersey, has a keen interest in veterinary emergency and critical care. In an interview with dvm360, ahead of the 2024 Fetch Coastal conference in Atlantic City, New Jersey, Roach discussed the topics she presented to attendees including diabetic ketoacidosis (DKA).

Managing feline diabetes mellitus with SGLT2i

Sodium-Glucose Cotransporter 2 inhibitors (SGLT2is) have been used in human medicine for several years. Recently, 2 specific SGLT2is saw their introduction to feline medicine: Bexagliflozin (Bexacat; Elanco), and velagliflozin oral solution (Senvelgo; Boehringer Ingelheim). Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ, explained how they work in the management of feline diabetes mellitus. Byers outlined the effectiveness of these medications on cats, and why it can prevent the development of clinical hypoglycemia, in an interview with dvm360.